Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Biothreat Advisory Board
  • Ecosystem
    • Overview
    • Subsidiaries
  • Products
    • Anthim
    • Publications
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Careers
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 16, 2020 7:30am EST

Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19

Dec 10, 2020 8:00am EST

Heat Biologics Provides Business Update

Nov 09, 2020 7:00am EST

Heat Biologics Provides Third Quarter 2020 Business Update

Oct 07, 2020 7:30am EDT

Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator

Sep 09, 2020 7:30am EDT

Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

Sep 02, 2020 7:30am EDT

Heat Biologics Issued Key Patent on Combination Platform Therapy

Aug 26, 2020 7:30am EDT

Heat Biologics Announces Publication of Preclinical COVID-19 Vaccine Results

Aug 13, 2020 7:00am EDT

Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies

Aug 07, 2020 7:00am EDT

Heat Biologics Provides Second Quarter 2020 Business Update

Aug 05, 2020 7:30am EDT

Heat Biologics Highlights Importance of T cell Immunity to Prevent COVID-19

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences

OUR ECOSYSTEM

SkunkWorx Bio
Elusys Therapeutics Inc.
Scorpius Biological Services
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.